David R. Shprecher
Expertise in
10
conditions

Dr. David R. Shprecher

Neurology
10515 W Santa Fe Dr, 
Sun City, AZ 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
10
conditions
10515 W Santa Fe Dr, 
Sun City, AZ 

Overview

Inspired by his experience as an individual with Tourette syndrome, Dr. Shprecher has dedicated his career to improving quality of life and treatment options for people with movement disorders. He utilizes a team approach to care involving physical therapy, speech therapy, social work and other important services. Most importantly, he involves his patient and their caregiver in decisions about their care. In order to identify more effective and better tolerated therapies, He frequently involves his patients directly in clinical trials conducted at his institute.

Dr. Shprecher is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Lewy Body Dementia (LBD), and Progressive Supranuclear Palsy.

Dr. Shprecher is board certified in Neurology (American Board Of Neurology And Psychiatry). He is actively involved in clinical research, co-authoring 65 peer reviewed articles and participating in 8 clinical trials. Dr. Shprecher is currently accepting new patients.

Residency

University of Utah

Specialties

Neurology

Licenses

Medicine in UT
Medicine in AZ

Board Certifications

Neurology (American Board Of Neurology And Psychiatry)

Fellowships

University of Rochester Medical Center, Movement Disorders, 2009

Hospital Affiliations

Banner Boswell, Sun City

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
PacificSource
  • PPO
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Legacy Healthcare Services Inc
10515 W Santa Fe Dr, Sun City, AZ 85351

Additional Areas of Focus

Dr. Shprecher has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Torticollis
Tardive Dyskinesia
Focal Dystonia
Corticobasal Degeneration
Lewy Body Dementia (LBD)
Progressive Supranuclear Palsy
Essential Tremor
Huntington Disease
Multiple System Atrophy
Parkinson's Disease
Secondary Parkinsonism
Tourette Syndrome
View 2 Less Areas of Focus-

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enrollment Status: Recruiting
Publish Date: February 28, 2024
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects With Early, Untreated Parkinson Disease
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects With Early, Untreated Parkinson Disease
Enrollment Status: Completed
Publish Date: June 01, 2026
A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
Enrollment Status: Completed
Publish Date: March 12, 2026
Intervention Type: Drug
Study Drug: CT1812
Study Phase: Phase 2
North American Prodromal Synucleinopathy Consortium
North American Prodromal Synucleinopathy Consortium
Enrollment Status: Enrolling_by_invitation
Publish Date: November 06, 2024
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
The Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI)
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: DaTscan
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, With an Active-Treatment Dose-Blinded Period, to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects With Parkinson's Disease
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, With an Active-Treatment Dose-Blinded Period, to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects With Parkinson's Disease
Enrollment Status: Terminated
Publish Date: February 28, 2022
Intervention Type: Drug
Study Drug: BIIB054
Study Phase: Phase 2
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Enrollment Status: Completed
Publish Date: July 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

65 Total Publications

Olfactory decline in aging: longitudinal trajectories and associations with cognitive decline and postmortem neuropathology.
Olfactory decline in aging: longitudinal trajectories and associations with cognitive decline and postmortem neuropathology.
Journal: medRxiv : the preprint server for health sciences
Published: May 07, 2026
Similar Doctors
Expertise in
29
conditions
Expertise in
29
conditions
Referral required
Before you request

Barrow MAMDC And Barrow Cognitive

240 W Thomas Rd, Ste 301, 
Phoenix, AZ 
 (14.7 miles away)
602-406-6262
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Marwan Sabbagh is a Neurologist practicing medicine in Phoenix, Arizona. Dr. Sabbagh is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Lewy Body Dementia (LBD), Movement Disorders, and Deep Brain Stimulation. Dr. Sabbagh is board certified in Psychiatry & Neurology (Neurology). Dr. Sabbagh is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

Neurosurgical Associates LTD.

2910 N 3rd Ave, 
Phoenix, AZ 
 (14.6 miles away)
602-406-3181
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashutosh Jadhav is a Neurologist practicing medicine in Phoenix, Arizona. Dr. Jadhav is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Stroke, Subarachnoid Hemorrhage, Brain Aneurysm, Thrombectomy, and Stent Placement.

Expertise in
16
conditions
Expertise in
16
conditions
Referral required
Before you request

Muhammad Ali Parkinson Center

240 West Thomas Road, Suite 301, 
Phoenix, AZ 
 (14.6 miles away)
602-406-6262
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

My mission, along with the Dignity Health Medical Group, is to focus on innovative clinical care and the pursuit of excellence through scholarly activities. This allows me to provide patients with state-of-the-art patient services and exceptional patient experiences. Dr. Shill is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Parkinson's Disease, Essential Tremor, Movement Disorders, Deep Brain Stimulation, and Tissue Biopsy. Dr. Shill is board certified in Psychiatry & Neurology (Neurology). Dr. Shill is currently accepting new patients.

Frequently Asked Questions about Dr. David R. Shprecher

How do I make an appointment with Dr. David R. Shprecher?

You can book an appointment with Dr. David R. Shprecher by calling their office at 623-832-6530. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David R. Shprecher a top-rated expert for Movement Disorders?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David R. Shprecher is classified as an Elite expert for Movement Disorders, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David R. Shprecher specialize in?

While Dr. David R. Shprecher is a Neurology, they have specific expertise in Movement Disorders, Parkinson's Disease, and Lewy Body Dementia (LBD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. David R. Shprecher participate in research or clinical trials?

Yes. Dr. David R. Shprecher has published 65 articles and abstracts on conditions like Movement Disorders. You can view a list of Dr. David R. Shprecher's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David R. Shprecher accept my insurance?

Dr. David R. Shprecher accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 623-832-6530 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shprecher's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile